Evidence map›Paper›PMID 40790741›Full record

ArticleThe European journal of neuroscience2025

Amyloid-Beta Pathology Increases Synaptic Engulfment by Glia in Feline Cognitive Dysfunction Syndrome: A Naturally Occurring Model of Alzheimer's Disease.

Robert I McGeachan, Lucy Ewbank, Meg Watt, Lorena Sordo, Alexandra Malbon, Muhammad Khalid F Salamat, Makis Tzioras, Joao Miguel De Frias, Jane Tulloch, Fiona Houston and 2 more

Abstract read
In one paragraph

Article in The European journal of neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Robert I McGeachanCentre for Discovery Brain Sciences, The University of Edinburgh, Edinburgh, UK.ORCID 0000-0003-1647-8642
Lucy EwbankCentre for Discovery Brain Sciences, The University of Edinburgh, Edinburgh, UK.
Meg WattThe Roslin Institute, The University of Edinburgh, Edinburgh, UK.
Lorena SordoDepartment of Pathology and Laboratory Medicine, University of California, Irvine.
Alexandra MalbonThe Hospital for Small Animals, Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Edinburgh, UK.
Muhammad Khalid F SalamatThe Roslin Institute, The University of Edinburgh, Edinburgh, UK.
Makis TziorasCentre for Discovery Brain Sciences, The University of Edinburgh, Edinburgh, UK.
Joao Miguel De FriasThe Hospital for Small Animals, Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Edinburgh, UK.
Jane TullochCentre for Discovery Brain Sciences, The University of Edinburgh, Edinburgh, UK.
Fiona HoustonThe Roslin Institute, The University of Edinburgh, Edinburgh, UK.
Danièlle Gunn-MooreThe Hospital for Small Animals, Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Edinburgh, UK.
Tara L Spires-JonesCentre for Discovery Brain Sciences, The University of Edinburgh, Edinburgh, UK.ORCID 0000-0003-2530-0598

Funding

Alzheimer's Research UK ARUK-EG2016A-6UK Dementia Research Institute UKDRI-Edin005Wellcome TrustWellcome Trust 225442/Z/22/Z
6 · The paper itself

Abstract

Feline cognitive dysfunction syndrome (CDS; a.k.a. feline dementia) is an age-related neurodegenerative disorder, comparable to dementia in people, characterised by behavioural changes such as increased vocalisation, altered social interactions, sleep-wake cycle, disorientation and house-soiling. Although the underlying mechanisms remain poorly understood, pathologies similar to those observed in Alzheimer's disease (AD) have been identified in the brains of aged or CDS-affected cats, including brain atrophy, neuronal loss, amyloid-beta plaques, tau pathology and cerebral amyloid angiopathy. Neuroinflammation and synapse loss, other important hallmarks of AD, may also play important roles in feline ageing and CDS, but these are yet to be explored. Several mechanisms of synapse loss have been described in human AD and mouse models of amyloidopathy, including synaptic accumulation of amyloid-beta and the aberrant induction of synaptic engulfment by microglia and astrocytes. In this study, immunohistochemistry and confocal microscopy were used to examine the parietal cortex of young (n = 7), aged (n = 10) and CDS-affected (n = 8) cats. Linear mixed effect modelling revealed that amyloid-beta accumulates within synapses in the aged and CDS-affected brain. Additionally, in the aged and CDS groups, there was microgliosis, astrogliosis and increased synaptic engulfment by microglia and astrocytes in regions with Aβ plaques. Further, microglia and astrocytes show increased internalisation of amyloid-beta-containing synapses near plaques. These findings suggest that amyloid-beta exerts a pathogenic effect in the feline brain, with mechanisms mirroring those seen in human AD. Importantly, these results support the use of feline CDS as a naturally occurring, translational model of Alzheimer's disease, offering valuable insights into AD pathogenesis and potential therapeutic targets.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesCat DiseasesCognitive DysfunctionNeurogliaSynapsesAnimalsBrainCatsDisease Models, AnimalFemaleMaleMicrogliaPlaque, AmyloidAmyloid beta-Peptides

Identifiers

PMID40790741
PMCPMC12340200

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.